Clinical Trials Sponsored by Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Total 201 results

Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Completed

Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment

Carcinoma，Non-Small-Cell Lung

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Unknown

A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL

B-cell Lymphoma

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Completed

Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

China
ACEA Therapeutics, Inc.
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Unknown

Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States
Sun Yat-sen University
Hangzhou ACEA Pharmaceutical Research Co., Ltd.; Acea Bio (Hangzhou) Co., Ltd.

Unknown

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer

Non-Small Cell Lung Cancer

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Guangdong Provincial People's Hospital; Acea Bio (Hangzhou) Co., Ltd.

Active, not recruiting

Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC

Metastatic Non-small Cell Lung Cancer

China
Acea Bio (Hangzhou) Co., Ltd.

Unknown

Safety Study of FLP Injection to Treat Tumor Patients

Advanced Cancer

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Guangdong Provincial People's Hospital

Unknown

Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC

Metastatic Non-small Cell Lung Cancer

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Guangdong Provincial People's Hospital

Not yet recruiting

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Advanced Non-small Cell Lung Cancer

China
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

[14C] Study on Mass Balance and Biotransformation of STI-1558 in Healthy Chinese Adult Male Subjects

COVID-19

China
Zhejiang ACEA Pharmaceutical Co. Ltd.

Recruiting

Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

Study to Access the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

COVID-19

China
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects

COVID-19

China
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558

COVID-19 Pneumonia

China
Zhejiang ACEA Pharmaceutical Co. Ltd.

Recruiting

A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)

AML, Adult

China
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients

SARS-CoV-2 Infection

China
Hangzhou GluBio Pharmaceutical Co., Ltd.

Recruiting

A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

Non-Hodgkin Lymphoma

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

United States
Hangzhou GluBio Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of GLB-001 in Patients With Myeloid Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloid Malignancy

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs (TARA)

Rheumatoid Arthritis

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects

Atopic Dermatitis

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.

Chronic Spontaneous Urticaria

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19

Mild to Moderate COVID-19

China
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

COVID-19 Infection

China
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Completed

Study of WPV01 in Healthy Subjects

Healthy Participants

China
Hangzhou Zenshine Pharmaceuticals Co., Ltd.

Terminated

Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Non-hodgkin Lymphoma

United States
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Withdrawn

A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI

NSCLC

China
Hangzhou Yirui Pharmaceutical Technology Co., Ltd

Not yet recruiting

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Hangzhou Yirui Pharmaceutical Technology Co., Ltd

Completed

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers

Psoriasis | Atopic Dermatitis

United States
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Recruiting

A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer

China
Guangzhou Virotech Pharmaceutical Co., Ltd.

Recruiting

A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors

Solid Tumor

China
Guangzhou Virotech Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors

Solid Tumor

Japan
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection

Acute Upper Respiratory Infection

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

Chronic Hepatitis B

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

Acute Upper Respiratory Infection

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Unknown

A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans

Arteriosclerosis Obliterans

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Unknown

The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B

Chronic Hepatitis B

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

Chronic Hepatitis B

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Unknown

The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis

Bacterial Vaginosis

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers

Cardiovascular Diseases

China
TLL Pharmaceutical, LLC

Completed

A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants

Healthy

United States
TLL Pharmaceutical, LLC

Withdrawn

Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis

Ulcerative Colitis

United States
Ganzhou Hemay Pharmaceutical Co., Ltd

Recruiting

A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

Behçet's Disease

China
Ganzhou Hemay Pharmaceutical Co., Ltd

Recruiting

Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis

Moderate to Severe Ulcerative Colitis

China
Ganzhou Hemay Pharmaceutical Co., Ltd

Completed

A Study of Hemay005 in Adult With Atopic Dermatitis

Hemay005, Atopic Dermatitis

China
Ganzhou Hemay Pharmaceutical Co., Ltd

Not yet recruiting

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd

Completed

In Vivo Mass Balance Study of [14C]Hemay005

Health Volunteer

China
Guangzhou Magpie Pharmaceuticals Co., Ltd.

Not yet recruiting

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets

Pulmonary Arterial Hypertension

Clinical Trials Sponsored by Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations